Article

Exploiting Synthetic Lethal Network for Precision Treatment of Clear Cell Renal Cell Carcinoma

2021-12-06

Abstract excerpt

<title>Abstract</title> <p>Background The emerging of targeted therapies has revolutionized the treatment modalities of advanced clear cell renal cell carcinoma (ccRCC) over the past fifteen years. However, lack of personalized treatment limits the development of effective clinical guidelines and improvement of patient prognosis. In this study, large-scale genomic profiles of ccRCC cohorts were exploited for con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d1669921-9737-58d4-9975-0d6697e1041f
DOI: 10.21203/rs.3.rs-958499/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploiting Synthetic Lethal Network for Precision Treatment of Clear Cell Renal Cell CarcinomaDOI 10.21203/rs.3.rs-958499/v1Read

Exploring synthetic lethal network for the precision treatment of clear cell renal cell carcinoma.Semantic proximity Read

SLOAD: a comprehensive database of cancer-specific synthetic lethal interactions for precision cancer therapy via multi-omics analysis.Semantic proximity Read

Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approachSemantic proximity Read

The tumor therapy landscape of synthetic lethality.Semantic proximity Read

Pan-Cancer Analysis of Potential Synthetic Lethal Drug Targets Specific to Alterations in DNA Damage ResponseSemantic proximity Read

Synthetic lethality on drug discovery: an update on cancer therapy.Semantic proximity Read

SLAYER: A Computational Framework for Identifying Synthetic Lethal Interactions through Integrated Analysis of Cancer DependenciesSemantic proximity Read

Challenges and opportunities for drug repurposing in cancers based on synthetic lethality induced by tumor suppressor gene mutationsSemantic proximity Read

A Methodological Workflow to Analyze Synthetic Lethality and Drug Synergism in Cancer Cells.Semantic proximity Read

Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.Semantic proximity Read

Treatment strategies for clear cell renal cell carcinoma: Past, present and futureSemantic proximity Read

The critical role of BAP1 mutation in the prognosis and treatment selection of kidney renal clear cell carcinomaSemantic proximity Read